Page last updated: 2024-11-02

moxonidine and Hyperlipemia

moxonidine has been researched along with Hyperlipemia in 4 studies

moxonidine: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Treatment with moxonidine in six patients who completed the study resulted in a 10/5 mmHg reduction in 24-h ambulatory blood pressure (p = 0."5.32Effect of moxonidine on lipid subfractions in patients with hypertension. ( Chik, G; Lumb, PJ; McMahon, Z; Wierzbicki, AS, 2004)
"Moxonidine has been shown to improve glucose tolerance in man, probably by two different mechanisms, i."2.40Therapy of hypertension and metabolic syndrome: today's standard and tomorrow's perspectives. ( Hansson, L, 1998)
"Treatment with moxonidine in six patients who completed the study resulted in a 10/5 mmHg reduction in 24-h ambulatory blood pressure (p = 0."1.32Effect of moxonidine on lipid subfractions in patients with hypertension. ( Chik, G; Lumb, PJ; McMahon, Z; Wierzbicki, AS, 2004)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lumb, PJ1
McMahon, Z1
Chik, G1
Wierzbicki, AS1
Velliquette, RA1
Kossover, R1
Previs, SF1
Ernsberger, P2
Hansson, L1
Koletsky, RJ1
Friedman, JE1

Reviews

1 review available for moxonidine and Hyperlipemia

ArticleYear
Therapy of hypertension and metabolic syndrome: today's standard and tomorrow's perspectives.
    Blood pressure. Supplement, 1998, Volume: 3

    Topics: Antihypertensive Agents; Humans; Hyperlipidemias; Hypertension; Imidazoles; Insulin Resistance; Obes

1998

Other Studies

3 other studies available for moxonidine and Hyperlipemia

ArticleYear
Effect of moxonidine on lipid subfractions in patients with hypertension.
    International journal of clinical practice, 2004, Volume: 58, Issue:5

    Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hyperlipidemias; Hypertension; Imidazoles;

2004
Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 372, Issue:4

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agon

2006
Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X.
    Annals of the New York Academy of Sciences, 1999, Nov-18, Volume: 892

    Topics: Animals; Anti-Obesity Agents; Carrier Proteins; Disease Models, Animal; Endocrine System; Female; Hy

1999